Sanofi Stock Quote 1SAN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

93.77

Bid

88.00

Ask

94.15

Volume

1,312

93.15 Day's Range 94.17

80.75 52 Week Range 104.22

Market Cap

115.819B

Previous Close

92.46

Open

93.24

Last Trade

93.77

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

969

Shares Outstanding

1,252,640,466

Dividend Yield

4.01%

PE Ratio

21.69

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 92.46 €. Over the last year, Sanofi shares have traded in a share price range of 80.75 € to 104.22 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 115.82 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.69.

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A

Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A NEJM publishes ALTUVIIIO...

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints d’hémophilie A sévère

Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints...

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Dupixent positive phase 3 data in children one to 11 years of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-0.0426393774651	93.81	94.17	90.86	875	91.95454857	DE
4	5.76	6.54471082831	88.01	94.85	88	1151	92.09931153	DE
12	1.41	1.52663490689	92.36	94.85	86.2	969	90.98859394	DE
26	0.16	0.170921910052	93.61	94.85	84.98	870	89.90251837	DE
52	-5.23	-5.28282828283	99	104.22	80.75	814	90.0310654	DE
156	6.89	7.93047882136	86.88	106.06	76.36	1077	89.96521405	DE
260	19.14	25.646522846	74.63	106.06	68	1546	87.01989201	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 2.71 (293.44%)	104.92M
CMAXCareMax Inc	$ 3.724 (135.70%)	39.93M
SERVServe Robotics Inc	$ 11.59 (53.51%)	101.19M
NUKKNukkleus Inc	$ 0.4232 (32.25%)	5.69M
SAVACassava Sciences Inc	$ 13.16 (30.56%)	7.24M
LGCBLinkage Global Inc	$ 3.6303 (-30.39%)	109.77k
CGBSCrown LNG Holdings Ltd	$ 1.06 (-24.82%)	1.59M
SLNASelina Hospitality PLC	$ 0.0369 (-21.99%)	34.31M
HEPAHepion Pharmaceuticals Inc	$ 0.8119 (-20.40%)	6.85M
MEDSTRxADE Health Inc	$ 11.7601 (-20.22%)	69.46k
NVDANVIDIA Corporation	$ 120.4796 (2.16%)	112.31M
NCPLNetcapital Inc	$ 0.1147 (10.29%)	106.87M
MIRAMIRA Pharmaceuticals Inc	$ 2.71 (293.44%)	104.92M
SERVServe Robotics Inc	$ 11.59 (53.51%)	101.19M
SQQQProShares UltraPro Short QQQ	$ 8.32 (-1.65%)	95.07M